Skip to main content
. 2015 Dec 17;8:3827–3835. doi: 10.2147/OTT.S92314

Figure 1.

Figure 1

Expression of miR-125a-5p in prostate cancer cell lines and clinical specimens.

Notes: (A) qRT-PCR was used to evaluate the expression levels of miR-125a-5p in AR-negative prostate cancer cell lines, DU145, PC-3, NCI-H660 cells and AR-positive prostate cancer cell lines, 22RV-1, LNCaP, VCaP cells. The control cell line is a nontumorigenic human prostate epithelial cell line RWPE-1. (*P<0.05 vs RWPE-1). (B) qRT-PCR was used to compare the expression levels of miR-125a-5p between paired T and ANT specimens in nine patients with prostate cancer (*P<0.05).

Abbreviations: qRT-PCR, quantitative reverse transcription-polymerase chain reaction; AR, androgen receptor; T, carcinoma tissues; ANT, adjacent noncarcinoma tissues.